Author name: admin

Develops Far-Infrared patches supporting natural and non-invasive wellness. KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 12 September 2025 – KPLASS, a manufacturer and brand of Far Infrared Technology patches, has received several awards at the Osaka World Expo 2025 namely the “Special Honour Product”, “Innovative Product Award”, “Distinguished Manufacturer Award” and “Outstanding Contribution Award”. Its Far Infrared Cough Relief Patch is available to consumers across Southeast Asia, including Malaysia, Singapore, Vietnam, Cambodia, and other markets. This recognition marks a notable milestone as KPLASS continues to expand in the region. The KPLASS Far Infrared Cough Relief Patch uses Far Infrared Technology combined with targeted acupoint stimulation. Unlike conventional heat pads that provide surface warmth, Far Infrared rays penetrate deeper layers of the skin and help in blood circulation and other bodily functions. When applied to acupoints such as TianTu and DanZhong, the patch is activated to emit gentle heat through the acupoints that could improve blood flow, reduce inflammation and provide relief from cough symptoms through a non-invasive method. “This recognition at the Osaka World Expo highlights our ongoing efforts in health and wellness innovation. By combining Far Infrared Technology with acupoint therapy, we aim to offer patches that are safe and effective for a wide range of users. We continue to focus on broadening access across Asia Pacific.” said Michael Hu, Founder and CEO of KPLASS Singapore. The KPLASS range includes the Far Infrared Adult Cough Relief Patch, as well as a Far Infrared Child Cough Relief Patch intended for children aged 3 months to 6 years. Additional products in the range target pain relief, joint pain relief, and menstrual relief. These patches are designed to complement the body’s natural processes and provide non-invasive support. KPLASS’s regional presence is growing in response to increased consumer interest in natural and technology-assisted health products, particularly in Malaysia. Plans are currently underway to introduce the Child Cough Relief Patch to the Malaysian market, complementing the existing adult range already available nationwide. In Singapore, KPLASS was named “Best Selling Cough Patch” by Watsons in 2022, 2024, and 2025, while the Child Cough Relief Patch continues to gain traction. KPLASS relief patches are available in Malaysia at Watsons, Guardian, Alpro, AA Pharmacy, Multicare, Healthlane, Pillbox stores and other pharmacies nationwide. For more information, please visit www.kplass.sg, or follow KPLASS on Instagram and Facebook for the latest updates. Image can be downloaded from this link – [Click Here]. Hashtag: #KPLASS #FarInfrared #Technology #Health http://www.kplass.sghttps://www.facebook.com/kplassmalaysia/?ref=_xav_ig_profile_page_webhttps://www.instagram.com/kplass_malaysia/ The issuer is solely responsible for the content of this announcement. About KPLASS KPLASS is a Singapore brand using leading edge of technology and healthcare innovation to alleviate daily body discomforts. It uses the Far Infrared technology, which is natural, safe and effective that helps to relieve the cough symptoms and various body pains. Backed by 25 years of R&D and manufacturing competency of its parent company, the marketing and offering are differentiated by combined Infrared technology and TCM Acupoints in everyday health care solutions that is drug free, non-invasive and thus convenient and user-friendly. Bring home the Infrared treatment at your comfort and convenience.

Tanoto Foundation presents findings at AVPN Global Conference HONG KONG SAR – Media OutReach Newswire – 12 September 2025 – At a time when governments, development agencies, and NGOs strive to address complex social challenges, the necessity to demonstrate real, sustainable results has never been greater. To remain effective, philanthropy must move with purpose, not only to fund initiatives but also to embrace measurement and evidence as a compass for decision-making and meaningful social change. To help the philanthropic sector do good, better, Tanoto Foundation launched The Evidence Behind Better Philanthropy report at the AVPN Global Conference in Hong Kong. The study, developed in partnership with the Centre for Evidence and Implementation (CEI), provides a first-of-its-kind comparative analysis of how leading global foundations practice monitoring, evaluation, and learning (MEL), a much-discussed but often elusive cornerstone of effective philanthropy. By combining in-depth interviews with foundation leaders and an extensive review of global practice, the report offers timely insights from some of the world’s most influential funders on how evidence is shaping strategy, guiding adaptation, and enabling more collaborative approaches to impact across diverse and complex contexts. Benny Lee, CEO of Tanoto Foundation, said: “For philanthropy to do good, it must also do better, because today’s challenges are more complex and interconnected. At Tanoto Foundation, we see evidence not just as a tool for accountability, but as a compass for strategy. By embedding monitoring, evaluation, and learning at the heart of decision-making, we can steward resources more effectively and contribute to meaningful, lasting social change.” The report identifies 10 key findings, clustered into three broad themes for the philanthropic sector: 1. Strategy and Decision-Making: Embedding evidence into strategy through integrated “SMEL” (Strategy, Monitoring, Evaluation, and Learning) ensures programmes are responsive and adaptive, reducing wasted resources and increasing policy effectiveness. 2. Culture and Capacity: A learning culture, backed by senior leadership and grantee capacity-building, enables funders and implementers to course-correct in real time – critical for large-scale reforms and systems change. 3. Tools and Ecosystem for Impact: Flexible evaluation methods, a focus on contribution over attribution, and strategic communication help funders, governments, and NGOs align their efforts and scale what works. Murni Leo, Global Head of Measurement, Learning and Evaluation at Tanoto Foundation, added: “This study reflects our belief that learning should not stop at compliance, but drive continuous improvement. At Tanoto Foundation, we have embedded MEL into how we design programmes, test assumptions, and adapt in real time. By sharing global practices openly, we hope to encourage a culture of collaboration where funders and partners alike can strengthen their use of evidence. When the sea rises, all boats rise—and MEL is one way to lift the sector together.” The report aims to support decision-makers across sectors to design more effective interventions, strengthen accountability, and collaborate for systemic change. The full report is now available and can be downloaded via the Tanoto Foundation website. Hashtag: #TanotoFoundation The issuer is solely responsible for the content of this announcement. About Tanoto Foundation At Tanoto Foundation, we unlock human potential, help communities thrive, and create lasting impact. Founded in 1981 by Sukanto Tanoto and Tinah Bingei Tanoto, we are an independent family foundation that believes in providing every person with the opportunity to realize his or her full potential. To do so, we catalyse systems change in education and healthcare. Our approach is impact-first, collaborative, and evidence-based. We invest for the long term and strive to develop leaders who can drive sustained, positive outcomes. More information is available at www.tanotofoundation.org/en/

Develops Far-Infrared patches supporting natural and non-invasive wellness. SINGAPORE – Media OutReach Newswire – 12 September 2025 – KPLASS, a manufacturer and brand of Far Infrared Technology patches, has received has received several awards at the Osaka World Expo 2025 namely the “Special Honour Product”, “Innovative Product Award”, “Distinguished Manufacturer Award” and “Outstanding Contribution Award”. Its Far Infrared Cough Relief Patch is available to consumers across Southeast Asia, including Malaysia, Singapore, Vietnam, Cambodia, and other markets. This recognition marks a notable milestone as KPLASS continues to expand in the region. KPLASS Recognised at Osaka World Expo 2025 for Breakthrough Far-Infrared Cough Relief Patch The KPLASS Far Infrared Cough Relief Patch uses Far Infrared Technology combined with targeted acupoint stimulation. Unlike conventional heat pads that provide surface warmth, Far Infrared rays penetrate deeper layers of the skin and help in blood circulation and other bodily functions. When applied to acupoints such as TianTu and DanZhong, the patch is activated to emit gentle heat through the acupoints that could improve blood flow, reduce inflammation and provide relief from cough symptoms through a non-invasive method. “This recognition at the Osaka World Expo highlights our ongoing efforts in health and wellness innovation. By combining Far Infrared Technology with acupoint therapy, we aim to offer patches that are safe and effective for a wide range of users. We continue to focus on broadening access across Asia Pacific.” said Michael Hu, Founder and CEO of KPLASS Singapore. The KPLASS range includes the Far Infrared Adult Cough Relief Patch as well as the Far Infrared Child Cough Relief Patch, designed for children aged 3 months to 6 years. Safe for both adults and young children, the patch offers a gentle yet effective alternative to traditional medication, suitable for use during the day or night. Additional products in the range target pain relief, joint pain relief, and menstrual relief, with each relief patch developed to work naturally with the body through a non-invasive approach. KPLASS’s regional presence is growing in response to increased consumer interest in natural and technology-assisted health products. In Singapore, KPLASS was named “Best Selling Cough Patch” by Watsons in 2022, 2024, and 2025, with the Child Cough Relief Patch gaining steady traction among parents seeking safe, drug-free options for their families. KPLASS relief patches are available at leading pharmacy chain like Guardian, Watsons and Unity and also online via Shopee and Lazada in Singapore. For more information, please visit www.kplass.sg, or follow KPLASS on Instagram and Facebook for the latest updates. Hashtag: #KPLASS #FarInfrared #Technology #Health http://www.kplass.sghttps://www.facebook.com/KplassSingaporehttps://www.instagram.com/kplass_singapore/ The issuer is solely responsible for the content of this announcement. About KPLASS KPLASS is a Singapore brand using leading edge of technology and healthcare innovation to alleviate daily body discomforts. It uses the Far Infrared technology, which is natural, safe and effective that helps to relieve the cough symptoms and various body pains. Backed by 25 years of R&D and manufacturing competency of its parent company, the marketing and offering are differentiated by combined Infrared technology and TCM Acupoints in everyday health care solutions that is drug free, non-invasive and thus convenient and user-friendly. Bring home the Infrared treatment at your comfort and convenience.

East Island 24-Hour Animal Hospital spans 11,000 sq ft across two floors, offering Fear Free® design, advanced medicine, and affordable premium care with extended consultation hours. HONG KONG SAR – Media OutReach Newswire – 12 September 2025 – Creature Comforts Veterinary Group, with over 23 years of history in Hong Kong, proudly introduces the East Island 24-Hour Animal Hospital in Shau Kei Wan. Spanning 11,000 square feet across two floors, it is Hong Kong Island’s first veterinary hospital purpose-built around Fear Free® principles. East Island 24 Hours Animal Hospital The facility offers a calming environment with dog-and-cat separation, soundproof feline wards, Rainbow Rooms for sensitive moments, and family lounges. Families can also access extended consultations until midnight, with seamless 24/7 emergency support. Behind the design lies advanced medical capability: real-time ICU monitoring, a dedicated blood bank with guaranteed delivery, laser therapy, a three-times larger isolation ward and expanded diagnostics (ultrasound, echocardiography, endoscopy). A CT scanner and a mobility-friendly animal lift will be added later this year. “High-quality veterinary medicine should not be limited to a select few. Premium care doesn’t need to come with premium pricing,” said Dr David, Medical Director. “When animals are calm, they recover better. And when owners feel safe, they can focus on supporting their pets rather than panicking,” added Dr Kaylen, Vet Manager. The hospital is also actively developing charity give-back projects, such as Adoption Day events with Paws United Charity, to support the community and promote pet adoption. For Creature Comforts, which began in 2002 as Hong Kong’s first house-call vet service, expanded with the Veterinary TKO Center in 2021, and now cares for more than 40,000 pets across the city, the new hospital is both a milestone and a promise: Fear Free®, advanced, and accessible care for every family. Media enquiries & access: Exclusive hospital tour and photo/video opportunities are available upon request. Hashtag: #CreatureComforts #24hoursAnimalHospital #FearFreeCare #AffordablePremiumCare #HKPets https://www.creaturecomforts.com.hk/en-twhttps://www.linkedin.com/company/creature-comforts-group/https://www.facebook.com/creaturecomfortshk/https://www.instagram.com/creaturecomfortshk/?hl=en The issuer is solely responsible for the content of this announcement. Creature Comforts Veterinary Group Creature Comforts has been serving Hong Kong pet families for over 23 years, beginning in 2002 as the city’s first house-call veterinary service and expanding with the Veterinary TKO Center in 2021. Today, the Group cares for more than 40,000 pets across the city. Its mission remains the same: to deliver Fear Free®, professional and compassionate veterinary care that is both high-quality and affordable.

HONG KONG SAR – Media OutReach Newswire – 12 September 2025 – Zentrogene Laboratory, an international genetic testing institution based in Hong Kong (under Sanai Health Industry Group 01889.HK), announced the launch of its ‘Y Precision’ testing technology based on Next-Generation Sequencing (NGS). This locally developed innovation in Hong Kong addresses longstanding industry challenges in gender determination for twin pregnancies. It overcomes the limitations of traditional qPCR platforms, achieving the first-ever precise identification of male-female twins while significantly enhancing the accuracy of fetal cell-free DNA (cfDNA) analysis. Illustration: IP Image Ambassador Dr.z Traditional methods could only qualitatively detect the presence of the Y chromosome, failing to distinguish between male-male twins and male-female twins. They also lacked the capability to identify residual male cfDNA after fetal reduction procedures. Zentrogene’s NGS-based technology achieves three breakthroughs: Fetal Signal Assessment: Utilizes whole-genome SNP scanning to confirm fetal signal presence, precisely quantify fetal fraction, and determine the number of fetal signals. Contamination Identification: Differentiates between false signals (e.g., contamination-derived Y chromosome fragments) and true fetal signals. Twin Pregnancy Precision Analysis: Independently analyzes X and Y chromosome fragments to accurately distinguish male-female twins from male-male twins. As a pioneer in Hong Kong’s genetic testing field, Zentrogene has established a global technology matrix covering pre-pregnancy, prenatal, and oncology applications through its integrated Sanger sequencing and NGS platforms. This NGS breakthrough underscores its ‘Technology-Driven Globalization’ strategy, leveraging Hong Kong’s expertise to deliver precision medical solutions worldwide. Zentrogene continues to advance genetic technology, safeguarding every family’s hopes with scientific rigor. For details, visit: https://www.zentrogene.com/ https://www.zentrogene.com.hk/ Official Cooperation Contacts: Telephone: +86 18051865085 (WeChat same number) Telegram: +855 99990026 Facebook: Zentrogene Hashtag: #Zentrogene The issuer is solely responsible for the content of this announcement.